Smartphone app could screen for neurological disease at home
University of California researchers have developed an app that uses a near-infrared camera to check for neurological disease.
By
Ophthalmology
Latest in
Ophthalmology
Pipeline Moves: Boehringer, Stealth BioTherapeutics likely to see clinical trial progress of ophthalmic assets scuppered
Clinical Trials Arena also reviews AstraZeneca's Phase I AZD-0466 cancer trial termination.
By
Skye retains CMAX Clinical Research for Phase I glaucoma treatment trial
The Phase I trial will assess the safety and pharmacokinetics of SBI-100 OE under GCP in healthy subjects.
Pipeline Moves: Terminations of fatty liver, blood cancer, ophthalmology clinical trials cause further study chances to nosedive
Bristol Myers Squibb, GT Biopharma, and Gemini Therapeutics terminate early-phase trials of their respective assets.
By
Annexon concludes enrolment in Phase II geographic atrophy treatment trial
The trial will assess the monthly and alternate-month dosing regimen of ANX007 in 270 patients.
Pipeline Moves: Phase I/II cystic fibrosis trial of Horizon asset cancelled, shot at further study drops
Novartis in uveal melanoma and Ascendis in hypoparathyroidism are also reviewed by Clinical Trials Arena.
By
VivaVision reports positive data from Phase II dry eye disease trial
In the trial, the improvement reported in the 5% treatment arm was greater than that observed in the vehicle.
Ocuphire concludes enrolment in Phase IIb diabetic retinopathy trial
The randomised, multicentre trial will analyse the safety and efficacy of APX3330 in patients with DR.